Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

DHR
Danaher Corporation
stock NYSE

At Close
Mar 26, 2026 3:59:59 PM EDT
187.93USD+0.419%(+0.78)3,694,971
0.00Bid   0.00Ask   0.00Spread
Pre-market
Mar 25, 2026 9:25:30 AM EDT
192.71USD+2.971%(+5.56)0
After-hours
Mar 26, 2026 4:11:30 PM EDT
188.95USD+0.540%(+1.02)11,815
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 28, 2022
02:05PM EST  Where Danaher Stands With Analysts   Benzinga
08:42AM EST  Wells Fargo Maintains Overweight on Danaher, Lowers Price Target to $330   Benzinga
Jan 27, 2022
07:08AM EST  Recap: Danaher Q4 Earnings   Benzinga
06:50AM EST  Danaher Q4 Results Beat Expectations, Clocks 21% Jump In Sales   Benzinga
06:43AM EST  Barclays Maintains Overweight on Danaher, Lowers Price Target to $325   Benzinga
06:13AM EST  Danaher Corp. (DHR) revealed earnings for its fourth quarter that increased from the same period last year and beat the Street estimates.   RTTNews
06:03AM EST  Danaher Q4 EPS $2.39; Non-GAAP EPS $2.69   RTTNews
06:01AM EST  Danaher Q4 EPS $2.69 Beats $2.51 Estimate, Sales $8.10B Beat $7.92B Estimate   Benzinga
06:01AM EST  Danaher Reports Fourth Quarter And Full Year 2021 Results   PR Newswire
04:37AM EST  Earnings Scheduled For January 27, 2022   Benzinga
Jan 26, 2022
10:51AM EST  Danaher's Earnings Outlook   Benzinga
Jan 24, 2022
12:25PM EST  Price To Earnings Ratio Insights For Danaher   Benzinga
Jan 11, 2022
12:09PM EST  What 5 Analyst Ratings Have To Say About Danaher   Benzinga
10:11AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2022   Benzinga
08:02AM EST  Pall Corporation's new Supralon(tm) Filter Element Advances Equipment   PR Newswire
06:43AM EST  Danaher Corp. (DHR) said Tuesday that it expects fourth quarter 2021 core revenue growth to be above its previously announced guidance.   RTTNews
06:32AM EST  Danaher Expects Q4 Core Revenue Growth To Be Above Prior Guidance   RTTNews
06:31AM EST  Danaher CEO to Comment on Financial Performance   PR Newswire
05:03AM EST  Bernstein Initiates Coverage On Danaher with Outperform Rating, Announces Price Target of $365   Benzinga
Jan 4, 2022
04:16PM EST  Danaher To Present At J.P. Morgan Healthcare Conference   PR Newswire
Dec 27, 2021
04:16PM EST  DANAHER SCHEDULES FOURTH QUARTER 2021 EARNINGS CONFERENCE CALL   PR Newswire
Dec 22, 2021
10:23AM EST  $1000 Invested In This Stock 5 Years Ago, Would Be Worth This Much   Benzinga
Dec 14, 2021
08:18AM EST  Wells Fargo Maintains Overweight on Danaher, Raises Price Target to $350   Benzinga
Dec 7, 2021
04:18PM EST  Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.21, Record Date 12/30/2021   RTTNews
04:18PM EST  Danaher Declares Dividend Of $0.21, Payable Jan. 28/record Dec. 30   RTTNews
04:16PM EST  Danaher Announces Quarterly Dividends   PR Newswire
Dec 2, 2021
11:16AM EST  Danaher's Debt Overview   Benzinga
Dec 1, 2021
09:50PM EST  Danaher Prices Offering Of $1 Bln Principal Amount Of 2.800% Senior Notes Due 2051   RTTNews
09:15PM EST  Danaher Announces Pricing Of Senior Notes Offering   PR Newswire
01:16PM EST  If You Invested $1000 Over The Past 10 Years In This Stock, Here's How Much You Would Have Today   Benzinga
11:12AM EST  Expert Ratings For Danaher   Benzinga
Nov 30, 2021
04:59PM EST  General Electric CEO Says Challenging Environment Will Persist   Benzinga
10:01AM EST  IDBS Polar(tm) Insight Brings Advanced Data Analytics and Visualization to   PR Newswire
Nov 29, 2021
07:02AM EST  Danaher To Redeem All Of EUR 800 Mln Aggregate Principal Amount Of 2.500% Senior Notes Due 2025   RTTNews
07:01AM EST  Danaher Announces Redemption Of Senior Notes   PR Newswire
Nov 23, 2021
04:16PM EST  Danaher To Present At Evercore ISI HealthCONx Conference   PR Newswire
Oct 22, 2021
12:32PM EDT  Expert Ratings For Danaher   Benzinga
10:57AM EDT  Barclays Maintains Overweight on Danaher, Raises Price Target to $355   Benzinga
09:15AM EDT  RBC Capital Maintains Sector Perform on Danaher, Raises Price Target to $334   Benzinga
07:43AM EDT  10 Biggest Price Target Changes For Friday   Benzinga
04:47AM EDT  Keybanc Maintains Overweight on Danaher, Raises Price Target to $345   Benzinga
Oct 21, 2021
12:12PM EDT  How Bad Are Danaher's Earnings? | Return On Invested Capital   Benzinga
12:12PM EDT  Danaher: Q3 Earnings Insights   Benzinga
12:12PM EDT  Danaher's Q3 Earnings Beats Street Estimates   Benzinga
12:11PM EDT  Danaher Q3 EPS $2.39 Beats $2.15 Estimate, Sales $7.20B Beat $7.00B Estimate   Benzinga
12:11PM EDT  Earnings Scheduled For October 21, 2021   Benzinga
06:26AM EDT  While announcing higher third-quarter results, science and technology innovator Danaher Corp. (DHR) said it expects fourth-quarter non-GAAP core revenue growth to be in the low-to-mid teens percent range. The company also raised its fiscal 2021 core revenue growth view.   RTTNews
06:03AM EDT  Danaher Corp. (DHR) revealed earnings for its third quarter that increased from last year.   RTTNews
06:02AM EDT  Danaher Q3 Adj. EPS From Cont. Ops. $2.39, Consensus $2.15   RTTNews
06:01AM EDT  Danaher Reports Third Quarter 2021 Results   PR Newswire
Oct 20, 2021
10:16AM EDT  A Preview Of Danaher's Earnings   Benzinga
Oct 19, 2021
09:50AM EDT  Price Over Earnings Overview: Danaher   Benzinga
Oct 12, 2021
04:31PM EDT  Danaher Releases 2021 Sustainability Report; Building A Strong Foundation Of   PR Newswire
Sep 28, 2021
12:17PM EDT  Here's How Much $100 Invested In Danaher 15 Years Ago Would Be Worth Today   Benzinga
06:02AM EDT  Danaher's Beckman Coulter Highlights Launch Of DxU Iris Workcell At AACC Annual Scientific Meeting & Clinical Lab Expo   Benzinga
06:01AM EDT  significantly reducing manual reviews to 4%(1) and cutting sample processing time by up to 78%(2)   PR Newswire
Sep 21, 2021
04:16PM EDT  Danaher Schedules Third Quarter 2021 Earnings Conference Call   PR Newswire
Sep 14, 2021
04:19PM EDT  Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.21, Record Date 9/30/2021   RTTNews
04:18PM EDT  Danaher Declares Quarterly Dividend Of $0.21/share, Payable Oct. 29/ Record Sept. 30   RTTNews
04:15PM EDT  Danaher Announces Quarterly Dividends   PR Newswire
Sep 10, 2021
07:36PM EDT  Where Danaher Stands With Analysts   Benzinga
08:29AM EDT  10 Biggest Price Target Changes For Friday   Benzinga
06:49AM EDT  Credit Suisse Maintains Outperform on Danaher, Raises Price Target to $370   Benzinga
Sep 8, 2021
12:36PM EDT  Expert Ratings For Danaher   Benzinga
07:38AM EDT  RBC Capital Maintains Sector Perform on Danaher, Raises Price Target to $332   Benzinga
Sep 1, 2021
11:00AM EDT  SCIEX Builds on Cadence of Innovation in Biopharma With Biologics Explorer   Business Wire
11:00AM EDT  SCIEX Presents Industry First Multi-Capillary System for CE-SDS, the BioPhase 8800 System   Business Wire
Aug 30, 2021
04:18PM EDT  Danaher Completes Acquisition Of Aldevron   RTTNews
Aug 25, 2021
04:30PM EDT  Danaher To Webcast Investor And Analyst Meeting   PR Newswire
Aug 24, 2021
08:32AM EDT  Danaher Says Effective April 1, 2022, Georgeann Couchara To Succeed Angela Lalor As SVP, Human Resources   RTTNews
08:31AM EDT  Danaher Announces Human Resources And Accounting Leadership Transition Plans   PR Newswire
Aug 20, 2021
12:17PM EDT  Danaher's Beckman Coulter On Aug. 18 Was Granted Emergency Use Authorization From FDA For Access SARS-CoV-2 IgG II Device   Benzinga
08:03AM EDT  Former Danaher President & CEO George Sherman Passes Away Earlier This Week After Illness   RTTNews
08:00AM EDT  Danaher Announces Passing of Former President & CEO, George M. Sherman   PR Newswire
Aug 19, 2021
02:39PM EDT  Danaher Block Trade Of 550K Shares At $315.70/Share   Benzinga
Jul 27, 2021
03:32AM EDT  Cytiva and Pall Corpor., part of the Danaher (DHR) Corp., said that they will expand manufacturing capacity and services across geographies for global life sciences customers.   RTTNews
02:46AM EDT  Cytiva And Pall Corp Investing $1.5 Bln Over Two Years; Plan To Hire 2000 Full-time Associates   RTTNews
02:05AM EDT  Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet   PR Newswire
Jul 26, 2021
08:33AM EDT  Beckman Coulter To Take Over Distribution To Customers Of B-type Natriuretic Peptide Assay   RTTNews
08:31AM EDT  Beckman Coulter to Distribute BNP Cardiac Assay to Customers   PR Newswire
Jul 23, 2021
03:02PM EDT  Where Danaher Stands With Analysts   Benzinga
09:07AM EDT  Barclays Maintains Overweight on Danaher, Raises Price Target to $335   Benzinga
08:11AM EDT  RBC Capital Maintains Sector Perform on Danaher, Raises Price Target to $304   Benzinga
Jul 22, 2021
07:17AM EDT  Danaher Posts Higher Profits, Margins On Increased Sales   Benzinga
07:06AM EDT  Recap: Danaher Q2 Earnings   Benzinga
06:08AM EDT  Danaher Corp. (DHR) announced earnings for its second quarter that rose from the same period last year.   RTTNews
06:03AM EDT  Danaher Q2 EPS $2.40 Vs. $1.24 Last Year   RTTNews
06:02AM EDT  Danaher Expects Q3 Sales Growth Will Be Mid-To High Teens Percentage   Benzinga
06:02AM EDT  Danaher Q2 EPS $2.46 Beats $2.05 Estimate, Sales $7.20B Beat $6.72B Estimate   Benzinga
06:01AM EDT  Danaher Reports Second Quarter 2021 Results   PR Newswire
04:02AM EDT  Earnings Scheduled For July 22, 2021   Benzinga
Jul 21, 2021
10:46AM EDT  A Preview Of Danaher's Earnings   Benzinga
Jul 20, 2021
10:32AM EDT  Price To Earnings Ratio Insights For Danaher   Benzinga
Jul 16, 2021
02:51PM EDT  What 6 Analyst Ratings Have To Say About Danaher   Benzinga
10:15AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 16, 2021   Benzinga
07:00AM EDT  Benchmark Initiates Coverage On Danaher with Buy Rating, Announces Price Target of $330   Benzinga
Jul 13, 2021
07:58AM EDT  Barclays Maintains Overweight on Danaher, Raises Price Target to $310   Benzinga
Jun 22, 2021
04:16PM EDT  Danaher Schedules Second Quarter 2021 Earnings Conference Call   PR Newswire
Jun 18, 2021
09:34AM EDT  Credit Suisse Maintains Outperform on Danaher, Raises Price Target to $288   Benzinga
Jun 17, 2021
10:03AM EDT  P/E Ratio Insights for Danaher   Benzinga
09:54AM EDT  Shares of Danaher Corp. (DHR) are currently trading at $252.35, up $7.61 or 3.11%, with trading volume rising over 500K versus an average volume of 2.43 million shares. The stock has been trading between $168.59 and $261.43 in the past one year.   RTTNews
09:25AM EDT  Science and technology firm Danaher Corp. (DHR) announced Thursday that it has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or proceeds from the issuance of commercial paper.   RTTNews
09:11AM EDT  Danaher Scoops Up Aldevron In $9.6B Deal   Benzinga
09:02AM EDT  Danaher To Buy Privately-held Aldevron For About $9.6 Bln In Cash   RTTNews
09:01AM EDT  Danaher To Acquire Aldevron   PR Newswire
09:01AM EDT  Danaher To Acquire Aldevron For ~$9.6B   Benzinga
Jun 10, 2021
10:22AM EDT  5 Things You Might Not Know About New GameStop CEO Matt Furlong   Benzinga
Jun 7, 2021
04:15PM EDT  Danaher To Present At Goldman Sachs Global Healthcare Conference   PR Newswire
May 27, 2021
04:15PM EDT  Danaher To Present At Jefferies Healthcare Conference   PR Newswire
May 13, 2021
04:41PM EDT  Danaher Appoints Shane Sanders To Its Board Of Directors   RTTNews
04:31PM EDT  Danaher Announces Appointment of A. Shane Sanders to Danaher Board   PR Newswire
May 5, 2021
04:26PM EDT  Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.21, Record Date 6/25/2021   RTTNews
04:16PM EDT  Danaher Announces Quarterly Dividends   PR Newswire
May 4, 2021
05:45PM EDT  Danaher To Present At Bank Of America Healthcare Conference   PR Newswire
Apr 26, 2021
09:36AM EDT  Barclays Maintains Overweight on Danaher, Raises Price Target to $300   Benzinga
09:02AM EDT  Danaher Announces Renowned Scientists To Join New Scientific Advisory Board   PR Newswire
Apr 23, 2021
10:07AM EDT  Wells Fargo Maintains Overweight on Danaher, Raises Price Target to $280   Benzinga
08:10AM EDT  10 Biggest Price Target Changes For Friday   Benzinga
06:10AM EDT  Keybanc Maintains Overweight on Danaher, Raises Price Target to $315   Benzinga
Apr 22, 2021
12:21PM EDT  Earnings Scheduled For April 22, 2021   Benzinga
09:35AM EDT  Danaher Earlier Report Co. Expects Q2 Sales Growth Will Be In The Mid- 20% Range; Expects FY21 Sales Growth Rate Including Cytiva To Be In The High-Teens Percentage Range   Benzinga
07:07AM EDT  Recap: Danaher Q1 Earnings   Benzinga
06:15AM EDT  Danaher Q1 EPS $2.52 Beats $1.75 Estimate, Sales $6.86B Beat $6.26B Estimate   Benzinga
06:12AM EDT  Danaher Corp. (DHR) announced a profit for its first quarter that rose from the same period last year.   RTTNews
06:04AM EDT  Danaher Q1 EPS $2.29 Vs $0.81 Last Year   RTTNews
06:01AM EDT  Danaher Reports First Quarter 2021 Results   PR Newswire
04:01AM EDT  Earnings Scheduled For April 22, 2021   Benzinga
Apr 13, 2021
10:17AM EDT  Shares of Danaher Corp. (DHR) are currently trading at $245.99, up $11.15 or 4.72%, with trading volume of over 2.16 million versus an average volume of 2.60 million shares.   RTTNews
07:12AM EDT  Danaher Projects Q1 Core Revenue Growth Above High-end Of   RTTNews
07:10AM EDT  Danaher Expects Q1 Sales Growth of ~57%   Benzinga
07:01AM EDT  Danaher Expects Q1 Core Revenue Growth To Be Above High-end Of Previously Communicated Guidance Range   RTTNews
07:01AM EDT  Danaher Provides Update On First Quarter 2021 Financial Performance   PR Newswire
Mar 25, 2021
05:00PM EDT  Danaher Schedules First Quarter 2021 Earnings Conference Call   PR Newswire
Mar 23, 2021
04:15PM EDT  /C O R R E C T I O N -- Beckman Coulter Diagnostics/   PR Newswire
01:55PM EDT  Danaher Says Co's Beckman Coulter SARS-CoV-2 IgG II Antibody Test Receives Emergency Use Authorization From FDA   Benzinga
01:54PM EDT  Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use   PR Newswire
Mar 18, 2021
02:15PM EDT  Beckman Coulter Offers $4/High-throughput Antigen Test to Support U.S.   PR Newswire
Mar 10, 2021
08:43AM EST  IIROC Trading Resumption - DHR   PR Newswire
Mar 9, 2021
01:21PM EST  IIROC Trading Halt - DHR   PR Newswire
Mar 4, 2021
04:16PM EST  Danaher To Present At Barclays Global Healthcare Conference   PR Newswire
Mar 3, 2021
10:02AM EST  Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2021   Benzinga
07:27AM EST  Barclays Initiates Coverage On Danaher with Overweight Rating, Announces Price Target of $260   Benzinga
Feb 23, 2021
04:22PM EST  Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.21, Record Date 3/26/2021   RTTNews
04:16PM EST  Danaher Announces Quarterly Dividends   PR Newswire
Feb 22, 2021
04:18PM EST  Danaher To Present At Cowen Healthcare Conference   PR Newswire
Feb 1, 2021
12:10AM EST  Cytiva Acquires Vanrx Pharmasystems   RTTNews
12:01AM EST  Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator   PR Newswire
Jan 29, 2021
10:02AM EST  P/E Ratio Insights for Danaher   Benzinga
Jan 28, 2021
07:07AM EST  Recap: Danaher Q4 Earnings   Benzinga
06:17AM EST  Danaher Corp. (DHR) revealed earnings for fourth quarter that decreased from last year.   RTTNews
06:14AM EST  Danaher Corp. (DHR) reported that its fourth quarter net earnings attributable to common stockholders declined to $1.20 billion or $1.66 per share from $1.26 billion or $1.73 per share in the previous year.   RTTNews
06:04AM EST  Danaher Q4 EPS $2.08 Beats $1.87 Estimate, Sales $6.76B Beat $6.53B Estimate   Benzinga
06:02AM EST  Danaher Q4 EPS From Cont Ops $1.66 Vs $1.07 Last Year   RTTNews
06:01AM EST  Danaher Reports Fourth Quarter And Full Year 2020 Results   PR Newswire
04:08AM EST  Earnings Scheduled For January 28, 2021   Benzinga
Jan 25, 2021
12:04PM EST  Beckman Coulter brings the productivity and efficiency benefits of large volume   PR Newswire
Jan 14, 2021
08:07AM EST  Credit Suisse Maintains Outperform on Danaher, Raises Price Target to $264   Benzinga
07:15AM EST  Cepheid, a unit of Danaher Corp. (DHR), said Thursday that it has received a medical device license from Health Canada for Xpert Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic test for qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and RSV infections from a single patient sample.   RTTNews
07:01AM EST  Cepheid Gets Health Canada License For SARS-CoV-2, Flu A, Flu B And RSV Combination Test   RTTNews
Jan 13, 2021
07:20AM EST  Danaher Boosts Q4 Revenue Growth Outlook - Quick Facts   RTTNews
07:18AM EST  A Look Into Danaher's Debt   Benzinga
07:04AM EST  UPDATE: Danaher Sees Q4 Sales Up ~38.5% Year Over Year   Benzinga
07:01AM EST  Danaher Estimates Q4 Revenues Up About 38.5% Year-over-year   RTTNews
07:00AM EST  Danaher CEO To Comment On Financial Performance At Co.'s J.P. Morgan Healthcare Conference Presentation At 10:50 a.m. ET.   Benzinga
06:59AM EST  Danaher CEO To Comment On Financial Performance   PR Newswire
Jan 7, 2021
04:15PM EST  Danaher To Present At J.P. Morgan Healthcare Conference   PR Newswire
04:15PM EST  Danaher Schedules Fourth Quarter 2020 Earnings Conference Call   PR Newswire
Dec 21, 2020
04:18PM EST  Danaher Announces Chief Scientific Officer Position   Benzinga
04:15PM EST  Danaher Announces Executive Appointment   PR Newswire
Dec 18, 2020
06:06AM EST  Danaher's Beckman Coulter Announces Launch Of Access SARS-CoV-2 Antigen Assay COVID-19 Antigen Test   Benzinga
Dec 14, 2020
08:01AM EST  Danaher announces leadership appointment   PR Newswire
Dec 8, 2020
04:22PM EST  Danaher Declares Quarterly Dividend Of $0.18/share, Payable Jan. 29/ Record Dec. 28   RTTNews
04:18PM EST  Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.18 , Record Date 12/28/2020   RTTNews
04:16PM EST  Danaher Announces Quarterly Dividend   PR Newswire
Nov 28, 2020
01:46PM EST  Notable Insider Buys in the Past Week: Biglari, Coty, Danaher, Foot Locker And More   Benzinga
Nov 25, 2020
03:49PM EST  RBC Downgrades Danaher, Says Defensive Portfolio 'Less Compelling To Own'   Benzinga
09:52AM EST  Benzinga's Top Upgrades, Downgrades For November 25, 2020   Benzinga
08:01AM EST  10 Biggest Price Target Changes For Wednesday   Benzinga
05:58AM EST  RBC Capital Downgrades Danaher to Sector Perform, Lowers Price Target to $234   Benzinga
Nov 24, 2020
05:00PM EST  Danaher To Present At Evercore ISI HealthCONx Conference   PR Newswire
Nov 23, 2020
09:13AM EST  Danaher's Debt Overview   Benzinga
08:09AM EST  Danaher's Beckman Coulter Launches Its Semi-Quantitative SARS-CoV-2 IgG II Antibody Test; Company Is Filing For Emergency Use Authorization Of The Assay With The FDA   Benzinga
08:04AM EST  Danaher Subsidiary Launches COVID-19 Antibody Test   Benzinga
08:03AM EST  Beckman Coulter Launches Access SARS-CoV-2 IgG II Assay   RTTNews
08:01AM EST  Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test   PR Newswire
01:47AM EST  GE Healthcare Acquires Swedish Start-up Prismatic Sensors To Bolster Its Medical Imaging Business   Benzinga
Nov 16, 2020
04:17PM EST  Danaher To Present At Wolfe Research Healthcare Conference   PR Newswire
Nov 10, 2020
04:16PM EST  Danaher Releases 2020 Sustainability Report   PR Newswire
09:31AM EST  Benzinga's Top Upgrades, Downgrades For November 10, 2020   Benzinga
03:03AM EST  Beckman Coulter Launches Access SARS-CoV-2 Immunoglobulin M Assay In Countries Accepting The CE Mark   RTTNews
03:00AM EST  Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries   PR Newswire
Nov 5, 2020
09:52AM EST  68 Stocks Trading Near 52-Week Highs Just After Open On Thursday, Nov. 5, 2020:   Benzinga
Oct 27, 2020
04:01AM EDT  Cytiva strengthens support to diagnostics industry with new labs, services and   PR Newswire
Oct 23, 2020
08:40AM EDT  Stocks Trading Near 52-Week Highs Before Open On Friday, Oct. 23, 2020: DHR, CRNC, DOGZ, BEAM, ARRY, FCX, BITA, SNAP   Benzinga
Oct 22, 2020
07:18AM EDT  Recap: Danaher Q3 Earnings   Benzinga
06:26AM EDT  Danaher Q3 EPS $1.72 Beats $1.36 Estimate   Benzinga
06:10AM EDT  While reporting financial results for the third quarter on Thursday, medical company Danaher Corp. (DHR) said it anticipates adjusted core revenue growth for the fourth quarter, including Cytiva, to be in the low-double digit range.   RTTNews
06:06AM EDT  Danaher Corp. (DHR) released a profit for its third quarter that rose from the same period last year.   RTTNews
06:03AM EDT  Danaher Q3 EPS $1.75 Beats $1.36 Estimate   Benzinga
06:02AM EDT  Danaher Q3 EPS From Cont Ops $1.16 Vs $0.84 Last Year   RTTNews
06:01AM EDT  Danaher Reports Third Quarter 2020 Results   PR Newswire
04:38AM EDT  Earnings Scheduled For October 22, 2020   Benzinga
Oct 21, 2020
10:13AM EDT  Earnings Preview: Danaher   Benzinga
Oct 20, 2020
09:04AM EDT  Cramer Gives His Opinion On Cloudera, Barrick Gold And More   Benzinga
Oct 15, 2020
08:30AM EDT  Beckman Coulter Receives BARDA Funding To Validate MDW   RTTNews
08:24AM EDT  Danaher's Beckman Coulter Receives BARDA Funding To Validate Monocyte Distribution Width In The Rapid Detection Of Multisystem Inflammatory Syndrome   Benzinga
08:11AM EDT  Beckman Coulter Gets BARDA Funding To Validate Monocyte Distribution Width In Rapid Detection Of MIS-C   RTTNews
08:02AM EDT  in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children   PR Newswire
Oct 14, 2020
07:18AM EDT  Cramer Advises Viewers On Quidel, Inseego And More   Benzinga
Oct 13, 2020
02:04PM EDT  Trump Administration Expands Manufacturing Capacity With Danaher's Cytiva For Components Of COVID-19 Vaccines   Benzinga
Oct 9, 2020
08:21AM EDT  Diagnostics company Beckman Coulter, Inc., a Danaher Corp. (DHR) company, announced Friday that its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).   RTTNews
08:02AM EDT  Beckman Coulter SARS-CoV-2 IgM Antibody Test Gets FDA Emergency Use Authorization   RTTNews
08:02AM EDT  Danaher's Beckman Coulter Reports Its Access SARS-CoV-2 Immunoglobulin Assay Received Emergency Use Authorization From FDA   Benzinga
08:01AM EDT  Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Use   PR Newswire
Oct 7, 2020
04:16PM EDT  Danaher Schedules Third Quarter 2020 Earnings Conference Call   PR Newswire
Oct 6, 2020
07:03AM EDT  Danaher To Redeem EUR 800 Mln Of 1.700% Senior Notes Due 2022   RTTNews
07:01AM EDT  Danaher Announces Redemption Of Senior Notes   PR Newswire
Oct 1, 2020
02:33PM EDT  Danaher Says FDA Emergency Use Authorization Awarded To Co's Subsidiary Beckman Coulter Access IL-6 Test   Benzinga
Sep 29, 2020
10:23PM EDT  Danaher Prices Offering Of $1 Bln Principal Amount Of 2.600% Senior Notes Due 2050 At Offering Price Of 98.970%   RTTNews
09:30PM EDT  Danaher Announces Pricing Of Senior Notes Offering   PR Newswire
07:51AM EDT  Cepheid's SARS-CoV-2/Flu/RSV Test Receives Emergency Use   RTTNews
07:07AM EDT  Danaher's Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B And RSV Combination Test   Benzinga
07:03AM EDT  Cepheid Gets Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B And RSV Combination Test   RTTNews
07:01AM EDT  Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and   PR Newswire
Sep 28, 2020
07:12AM EDT  Cramer Shares His Thoughts On Boeing, General Electric And More   Benzinga
Sep 25, 2020
05:45PM EDT  Correction Notice To Press Release Regarding Dividend Amount   PR Newswire
Sep 17, 2020
07:18PM EDT  'Halftime Report' Traders Share Their Thoughts On Danaher, Uber And IBM   Benzinga
Sep 15, 2020
04:24PM EDT  Danaher Declares Quarterly Dividend Of $0.18/share, Payable Oct. 30/ Record Sept. 28   RTTNews
04:19PM EDT  Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.18, Record Date 9/28/2020   RTTNews
04:15PM EDT  Danaher Announces Quarterly Dividend   PR Newswire
09:02AM EDT  Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection   PR Newswire
Sep 13, 2020
03:00PM EDT  5 years, 500 million USD, and nearly 1,000 people: Cytiva invests for global   PR Newswire
Sep 1, 2020
04:20PM EDT  Danaher Appoints Rainer Blair As President And CEO   RTTNews
Aug 24, 2020
08:12AM EDT  Beckman Coulter announced the launch of its Access SARS-CoV-2 Immunoglobulin M assay, new antibody test. The company said the test showed 99.9% specificity against 1,400 negative samples and 98.3% sensitivity at 15-30 days post-symptom onset.   RTTNews
08:11AM EDT  Danaher Launches COVID-19 Antibody Test   Benzinga
08:03AM EDT  Beckman Coulter Launches SARS-CoV-2 IgM Antibody Test; To Begin Shipping To U.S. Diagnostics Labs   RTTNews
08:01AM EDT  Beckman Coulter Launches SARS-CoV-2 IgM Antibody Test and will begin shipping   PR Newswire
Jul 27, 2020
10:44AM EDT  UBS Maintains Buy on Danaher, Raises Price Target to $233   Benzinga
07:30AM EDT  Needham Maintains Buy on Danaher, Raises Price Target to $209   Benzinga
Jul 24, 2020
10:59AM EDT  Stifel Maintains Hold on Danaher, Raises Price Target to $210   Benzinga
09:32AM EDT  Jefferies Maintains Buy on Danaher, Raises Price Target to $230   Benzinga
Jul 23, 2020
08:12AM EDT  Danaher's Beckman Coulter's Automated Blood Banking Analyzer Receives 510(k) FDA Clearance   Benzinga
08:02AM EDT  Beckman Coulter's Automated Blood Banking Analyzer Receives 510(k) FDA Clearance   PR Newswire
07:10AM EDT  Danaher: Q2 Earnings Insights   Benzinga
06:14AM EDT  Danaher Q2 Adj. EPS $1.44 Beats $1.08 Estimate, Sales $5.30B Beat $4.94B Estimate   Benzinga
06:13AM EDT  While reporting financial results for the second quarter on Thursday, medical company Danaher Corp. (DHR) said it anticipates adjusted core revenue growth for the third quarter, including Cytiva, to be in the mid- to high-single digit range.   RTTNews
06:11AM EDT  Danaher Corp. (DHR) revealed earnings for its second quarter that increased from last year.   RTTNews
06:01AM EDT  Danaher Q2 EPS $1.24 Vs $0.90 Last Year   RTTNews
06:01AM EDT  Danaher Reports Second Quarter 2020 Results   PR Newswire
04:30AM EDT  Earnings Scheduled For July 23, 2020   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC